Alfena

Researchers are evaluating the C-mo System's ability to automatically detect and characterize cough in patients aged 2 years and older who experience cough as a key or persistent symptom. The study focuses on whether the system can accurately identify cough events and analyze their intensity, type, and the presence of wheezing. This research aims to improve understanding and monitoring of cough in various conditions such as asthma, chronic obstructive pulmonary disease, gastroesophageal reflux, and idiopathic pulmonary fibrosis. Participants will use the C-mo System device for a continuous 24-hour period to monitor cough characteristics. During this time, they will wear the C-mo wearable device placed on the epigastric region. Participants will also keep a diary documenting relevant activities throughout the monitoring period and complete questionnaires about cough frequency and intensity, device usability, and how cough affects their quality of life. Throughout the study, researchers will measure cough detection accuracy and characterization using various statistical metrics over the 24-hour monitoring period. The study will assess cough detection precision, recall, F1-score, and wheezing detection accuracy. Participants' adherence and experiences with the device and cough impact will be monitored through diaries and questionnaires. The total participation involves a single 24-hour monitoring session with follow-up assessments based on the collected data.